Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Virginia Oncology Associates - Norfolk
mi
from
Norfolk, VA
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Virginia Oncology Associates - Norfolk
mi
from
Norfolk, VA
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Oncology and Hematology Associates of Southwest Virginia
mi
from
Roanoke, VA
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Oncology and Hematology Associates of Southwest Virginia
mi
from
Roanoke, VA
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
St Mary's Medical Center
mi
from
Huntington, WV
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
St Mary's Medical Center
mi
from
Huntington, WV
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Ministry Medical Group - Northern Region
mi
from
Rhinelander, WI
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Ministry Medical Group - Northern Region
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
McGill University
mi
from
Montreal,
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
McGill University
mi
from
Montreal,
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Coastal Clinical Research Inc
mi
from
Mobile, AL
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Coastal Clinical Research Inc
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Avail Clinical
mi
from
Deland, FL
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Avail Clinical
mi
from
Deland, FL
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Miami Research Associates
mi
from
Miami, FL
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Miami Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Palm Beach Research Center
mi
from
Palm Beach, FL
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Palm Beach Research Center
mi
from
Palm Beach, FL
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Johnson County Clin-Trials
mi
from
Lenexa, KA
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Johnson County Clin-Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
University of Kentucky
mi
from
Lexington, KY
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Central Kentucky Research
mi
from
Lexington, KY
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Central Kentucky Research
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Boston University
mi
from
Boston, MA
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
St. Louis University
mi
from
St Louis, MO
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
St. Louis University
mi
from
St Louis, MO
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Coastal Carolina Research
mi
from
Mt. Pleasant, SC
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Coastal Carolina Research
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Research Across America
mi
from
Dallas, TX
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Research Across America
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Jean Brown Research
mi
from
Salt Lake City, UT
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Jean Brown Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
University of Vermont
mi
from
Burlington, VT
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Emory University
mi
from
Atlanta, GA
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated:  7/15/2015
Heartland Research
mi
from
Witchita, KA
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Status: Enrolling
Updated: 7/15/2015
Heartland Research
mi
from
Witchita, KA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Scottsdale, AZ
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Oceanside, CA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
San Francisco, CA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Hamden, CT
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Hamden, CT
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Hartford, CT
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Gainesville, FL
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Miami, FL
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Winter Park, FL
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Atlanta, GA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Crestview Hills, KY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Lexington, KY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Louisville, KY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Baltimore, MD
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Boston, MA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Boston, MA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Plymouth, MN
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Plymouth, MN
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Columbia, MO
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Columbia, MO
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Lebanon, NH
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Lake Success, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
New York, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Rochester, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Troy, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Troy, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Charlotte, NC
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Raleigh, NC
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Cincinnati, OH
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials